[{"id":"a92567f3-a2f6-4354-a32d-d8bcd82ea384","acronym":"","url":"https://clinicaltrials.gov/study/NCT01598298","created_at":"2021-01-18T06:50:01.896Z","updated_at":"2024-07-02T16:35:58.973Z","phase":"Phase 3","brief_title":"S1202: Duloxetine Hydrochloride for Muscle/Joint Pain in Early-Stage Breast Cancer Receiving Hormone Therapy","source_id_and_acronym":"NCT01598298","lead_sponsor":"Southwest Oncology Group","biomarkers":" ER • PGR","pipe":"","alterations":" ","tags":["ER • PGR"],"overall_status":"Completed","enrollment":" Enrollment 299","initiation":"Initiation: 05/15/2013","start_date":" 05/15/2013","primary_txt":" Primary completion: 12/01/2016","primary_completion_date":" 12/01/2016","study_txt":" Completion: 12/20/2018","study_completion_date":" 12/20/2018","last_update_posted":"2022-12-16"},{"id":"07fd8cef-c29a-413c-862a-1abe2245a21c","acronym":"","url":"https://clinicaltrials.gov/study/NCT05510856","created_at":"2022-08-26T13:58:43.138Z","updated_at":"2024-07-02T16:36:02.090Z","phase":"Phase 4","brief_title":"Comparative Clinical Study Evaluating the Possible Efficacy of Duloxetine, Gabapentin and Lacosamide on Oxaliplatin-Induced Peripheral Neuropathy in Cancer Patients","source_id_and_acronym":"NCT05510856","lead_sponsor":"Tanta University","biomarkers":" HMOX1 • NEFL","pipe":"","alterations":" ","tags":["HMOX1 • NEFL"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e oxaliplatin"],"overall_status":"Recruiting","enrollment":" Enrollment 90","initiation":"Initiation: 09/01/2022","start_date":" 09/01/2022","primary_txt":" Primary completion: 09/01/2023","primary_completion_date":" 09/01/2023","study_txt":" Completion: 09/01/2024","study_completion_date":" 09/01/2024","last_update_posted":"2022-10-20"},{"id":"d2679ca7-9042-4bed-852b-63236c0c9327","acronym":"TIPN","url":"https://clinicaltrials.gov/study/NCT04732455","created_at":"2021-02-01T16:58:07.901Z","updated_at":"2024-07-02T16:36:07.541Z","phase":"","brief_title":"Lidocaine Versus Duloxetine for the Prevention of Taxane-Induced Peripheral Neuropathy In Breast Cancer Patients","source_id_and_acronym":"NCT04732455 - TIPN","lead_sponsor":"Gamal Mohamed Taha Abouelmagd","biomarkers":" CD8 • NCAM1","pipe":"","alterations":" ","tags":["CD8 • NCAM1"],"overall_status":"Completed","enrollment":" Enrollment 60","initiation":"Initiation: 01/15/2021","start_date":" 01/15/2021","primary_txt":" Primary completion: 06/08/2022","primary_completion_date":" 06/08/2022","study_txt":" Completion: 07/05/2022","study_completion_date":" 07/05/2022","last_update_posted":"2022-07-11"}]